Latest Foreign Investment Review Board News

Global Uranium and Enrichment Limited has entered a new funding agreement with Summit Strategies LLC, raising an additional A$2.5 million through convertible notes to support its ongoing operations and merger obligations with Snow Lake Resources.

Mayne Pharma has received notice of Cosette Pharmaceuticals' intention to appeal a court ruling in their acquisition dispute, potentially delaying the proposed takeover. The legal saga continues as key approvals and hearings loom.

AGL Energy has agreed to divest 19.9% of its 20% stake in Tilt Renewables for $750 million, reinforcing its strategy to recycle capital and invest in flexible energy capacity while maintaining a strategic partnership.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a regulatory delay as the Foreign Investment Review Board extends its approval deadline, pushing the court hearing to mid-November.

Mayne Pharma updates shareholders on the extended Foreign Investment Review Board approval deadline and the rescheduled court hearing for its acquisition scheme by Cosette Australia BidCo.

Aquirian Limited has completed a strategic review of its Wubin Energetics Precinct and entered a framework agreement with Hongda Civil Blasting Group to establish a joint venture for an automated electronic detonator facility in Western Australia.

Pepper Money and KKR have agreed to acquire Westpac’s RAMS home loan portfolio, marking a significant move in Australia’s mortgage servicing landscape. The $21.4 billion portfolio acquisition aligns with Pepper Money’s strategy to expand its capital-light servicing business.

Toro Energy has agreed to be acquired by IsoEnergy in a deal valuing Toro shares at a 79.7% premium, combining uranium assets across Australia, Canada, and the US. The transaction promises enhanced scale and exposure to tier-one uranium projects, pending shareholder and regulatory approvals.

The Treasurer has expressed preliminary concerns that Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma could harm Australia’s economy, citing plans to close a key Adelaide manufacturing site. Mayne Pharma disputes these claims and urges a resolution before the scheme deadline.

PhosCo has received a €1 million grant from the European Bank for Reconstruction and Development alongside a $1.1 million investment from its Managing Director, fueling optimisation efforts ahead of the Gasaat Phosphate Project’s bankable feasibility study.

Suzerain Investments Holdings Limited has initiated an off-market takeover bid for all remaining shares of Entertainment Rewards Ltd (EAT) at $0.022 per share, a substantial premium over recent trading prices. The offer comes with unanimous support from EAT's Independent Board Committee, subject to regulatory approvals and an independent expert's fairness opinion.

Pearl Gull Iron Limited has entered a binding agreement to sell its Cockatoo Island Project for A$4.5 million in cash, a 4% equity interest in Crestlink Pty Ltd, and royalties on extracted materials, with completion expected in Q4 2025.